Exosens (EPA:EXENS)
France flag France · Delayed Price · Currency is EUR
65.20
+0.60 (0.93%)
Apr 2, 2026, 5:35 PM CET

Exosens Statistics

Total Valuation

Exosens has a market cap or net worth of EUR 3.31 billion. The enterprise value is 3.50 billion.

Market Cap3.31B
Enterprise Value 3.50B

Important Dates

The next confirmed earnings date is Tuesday, July 28, 2026.

Earnings Date Jul 28, 2026
Ex-Dividend Date n/a

Share Statistics

Exosens has 50.70 million shares outstanding. The number of shares has decreased by -0.07% in one year.

Current Share Class 50.70M
Shares Outstanding 50.70M
Shares Change (YoY) -0.07%
Shares Change (QoQ) n/a
Owned by Insiders (%) 0.58%
Owned by Institutions (%) 26.97%
Float 30.36M

Valuation Ratios

The trailing PE ratio is 47.19 and the forward PE ratio is 34.35. Exosens's PEG ratio is 2.12.

PE Ratio 47.19
Forward PE 34.35
PS Ratio 7.06
PB Ratio 7.42
P/TBV Ratio 49.93
P/FCF Ratio 66.21
P/OCF Ratio 33.05
PEG Ratio 2.12
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 26.28, with an EV/FCF ratio of 70.17.

EV / Earnings 82.01
EV / Sales 7.48
EV / EBITDA 26.28
EV / EBIT 33.65
EV / FCF 70.17

Financial Position

The company has a current ratio of 2.46, with a Debt / Equity ratio of 0.60.

Current Ratio 2.46
Quick Ratio 1.54
Debt / Equity 0.60
Debt / EBITDA 2.00
Debt / FCF 5.34
Interest Coverage 8.61

Financial Efficiency

Return on equity (ROE) is 16.36% and return on invested capital (ROIC) is 13.24%.

Return on Equity (ROE) 16.36%
Return on Assets (ROA) 7.67%
Return on Invested Capital (ROIC) 13.24%
Return on Capital Employed (ROCE) 13.60%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 312,333
Profits Per Employee 28,496
Employee Count1,499
Asset Turnover 0.55
Inventory Turnover 1.89

Taxes

In the past 12 months, Exosens has paid 17.99 million in taxes.

Income Tax 17.99M
Effective Tax Rate 20.40%

Stock Price Statistics

The stock price has increased by +89.48% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +89.48%
50-Day Moving Average 60.42
200-Day Moving Average 48.30
Relative Strength Index (RSI) 54.53
Average Volume (20 Days) 163,431

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Exosens had revenue of EUR 468.19 million and earned 42.72 million in profits. Earnings per share was 0.84.

Revenue468.19M
Gross Profit 281.19M
Operating Income 104.10M
Pretax Income 88.18M
Net Income 42.72M
EBITDA 128.97M
EBIT 104.10M
Earnings Per Share (EPS) 0.84
Full Income Statement

Balance Sheet

The company has 68.63 million in cash and 266.47 million in debt, with a net cash position of -197.84 million or -3.90 per share.

Cash & Cash Equivalents 68.63M
Total Debt 266.47M
Net Cash -197.84M
Net Cash Per Share -3.90
Equity (Book Value) 445.65M
Book Value Per Share 8.79
Working Capital 166.53M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 100.00 million and capital expenditures -50.07 million, giving a free cash flow of 49.93 million.

Operating Cash Flow 100.00M
Capital Expenditures -50.07M
Depreciation & Amortization 24.87M
Net Borrowing -5.63M
Free Cash Flow 49.93M
FCF Per Share 0.98
Full Cash Flow Statement

Margins

Gross margin is 60.06%, with operating and profit margins of 22.24% and 9.12%.

Gross Margin 60.06%
Operating Margin 22.24%
Pretax Margin 18.83%
Profit Margin 9.12%
EBITDA Margin 27.55%
EBIT Margin 22.24%
FCF Margin 10.66%

Dividends & Yields

This stock pays an annual dividend of 0.30, which amounts to a dividend yield of 0.46%.

Dividend Per Share 0.30
Dividend Yield 0.46%
Dividend Growth (YoY) n/a
Years of Dividend Growth 1
Payout Ratio 11.89%
Buyback Yield 0.07%
Shareholder Yield 0.53%
Earnings Yield 1.29%
FCF Yield 1.51%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Exosens has an Altman Z-Score of 3.95 and a Piotroski F-Score of 6.

Altman Z-Score 3.95
Piotroski F-Score 6